ICCC
ICCC
NASDAQ · Biotechnology

Immucell Corp

$9.88
-0.05 (-0.45%)
As of Sep 28, 10:28 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target -56.8% upside
Low Target $3.74
Average Target $4.27
High Target $6.64
Current Price $9.88
Current
$9.88
Target
$4.27
$3.74 $4.27 avg $6.64
Scenario Analysis
Bear Case
$3.74
-62.1%
Low target
Base Case
$4.27
-56.8%
Avg target
Bull Case
$6.64
+-32.8%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$12.10
-18.3% from high
52-Week Low
$4.52
+118.6% from low
Target vs 52W High
$4.27
-64.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%